Follow
Emmanuelle Meuillet
Emmanuelle Meuillet
TheraxenTechnologies
Verified email at theraxentechnologies.com
Title
Cited by
Cited by
Year
A roadmap for interpreting 13C metabolite labeling patterns from cells
JM Buescher, MR Antoniewicz, LG Boros, SC Burgess, H Brunengraber, ...
Current opinion in biotechnology 34, 189-201, 2015
5092015
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth
Y Hu, L Qiao, S Wang, S Rong, EJ Meuillet, M Berggren, A Gallegos, ...
Journal of medicinal chemistry 43 (16), 3045-3051, 2000
2462000
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor …
EJ Meuillet, D Mahadevan, M Berggren, A Coon, G Powis
Archives of biochemistry and biophysics 429 (2), 123-133, 2004
2192004
Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides
EA Miljan, EJ Meuillet, B Mania-Farnell, D George, H Yamamoto, ...
Journal of Biological Chemistry 277 (12), 10108-10113, 2002
1842002
Deoxycholic acid induces intracellular signaling through membrane perturbations
S Jean-Louis, S Akare, MA Ali, EA Mash, E Meuillet, JD Martinez
Journal of Biological Chemistry 281 (21), 14948-14960, 2006
1272006
NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1NM23-H2 and c-Myc Activation
TS Dexheimer, SS Carey, S Zuohe, VM Gokhale, X Hu, LB Murata, ...
Molecular cancer therapeutics 8 (5), 1363-1377, 2009
1232009
Specific Inhibition of the Akt1 Pleckstrin Homology Domain by D-3-Deoxy-Phosphatidyl-myo-Inositol Analogues
EJ Meuillet, D Mahadevan, H Vankayalapati, M Berggren, R Williams, ...
Molecular cancer therapeutics 2 (4), 389-399, 2003
1172003
mPGES-1 as a target for cancer suppression: A comprehensive invited review “Phospholipase A2 and lipid mediators”
M Nakanishi, V Gokhale, EJ Meuillet, DW Rosenberg
Biochimie 92 (6), 660-664, 2010
1132010
Identification and development of mPGES-1 inhibitors: where we are at?
HH Chang, EJ Meuillet
Future medicinal chemistry 3 (15), 1909-1934, 2011
1112011
Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings
E Meuillet, S Stratton, D Prasad Cherukuri, AC Goulet, J Kagey, ...
Journal of cellular biochemistry 91 (3), 443-458, 2004
1112004
Gene transfection-mediated overexpression of β1, 4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function
A Rebbaa, H Yamamoto, T Saito, E Meuillet, P Kim, DS Kersey, ...
Journal of Biological Chemistry 272 (14), 9275-9279, 1997
991997
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells
DP Cherukuri, XBO Chen, AC Goulet, RN Young, Y Han, RL Heimark, ...
Experimental cell research 313 (14), 2969-2979, 2007
972007
Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine
KM Block, H Wang, LZ Szabó, NW Polaske, LK Henchey, R Dubey, ...
Journal of the American Chemical Society 131 (50), 18078-18088, 2009
962009
Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’)
B Stea, R Falsey, K Kislin, J Patel, H Glanzberg, S Carey, AA Ambrad, ...
Cancer letters 202 (1), 43-51, 2003
962003
Submolecular regulation of cell transformation by deuterium depleting water exchange reactions in the tricarboxylic acid substrate cycle
LG Boros, DP D’Agostino, HE Katz, JP Roth, EJ Meuillet, G Somlyai
Medical hypotheses 87, 69-74, 2016
902016
Discovery of a novel class of AKT pleckstrin homology domain inhibitors
D Mahadevan, G Powis, EA Mash, B George, VM Gokhale, S Zhang, ...
Molecular cancer therapeutics 7 (9), 2621-2632, 2008
842008
Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain InhibitorPharmacology and …
EJ Meuillet, S Zuohe, R Lemos, N Ihle, J Kingston, R Watkins, SA Moses, ...
Molecular cancer therapeutics 9 (3), 706-717, 2010
792010
Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431
EJ Meuillet, R Kroes, H Yamamoto, TG Warner, J Ferrari, B Mania-Farnell, ...
Cancer Research 59 (1), 234-240, 1999
771999
Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase–dependent clonogenic response in acute myeloid leukemia cells
AF List, B Glinsmann-Gibson, C Stadheim, EJ Meuillet, W Bellamy, ...
Experimental Hematology 32 (6), 526-535, 2004
762004
Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431
EJ Meuillet, B Mania-Farnell, D George, JI Inokuchi, EG Bremer
Experimental Cell Research 256 (1), 74-82, 2000
762000
The system can't perform the operation now. Try again later.
Articles 1–20